![]() |
|
|
Vol. 29, Issue 12, 1529-1534, December 2001
Department of Pharmacology and Experimental Therapeutics and
The Stanley S. Scott Cancer Center, Louisiana State University Health
Sciences Center, New Orleans, Louisiana
Recent studies have demonstrated that the catalytic behavior of one
cytochrome P450 (P450) enzyme can be influenced by the presence of a
second P450. This effect has been observed using reconstituted systems
containing reductase, CYP2B4, and CYP1A2, primarily at subsaturating
reductase. Addition of 1A2 caused a 75% inhibition of CYP2B4-dependent
7-pentoxyresorufin-O-dealkylation (PROD). Conversely,
CYP2B4-dependent benzphetamine (bzp) demethylation did not exhibit this
response after CYP1A2 addition. Addition of CYP2B4 to a reconstituted
system containing reductase and CYP1A2 caused synergism of
CYP1A2-dependent 7-ethoxyresorufin-O-dealkylation (EROD). This behavior was consistent with the formation of heteromeric CYP1A2-CYP2B4 complexes with altered catalytic properties.
Although such responses have been documented in reconstituted systems, they have not been demonstrated in microsomal preparations. The goal of
the present study was to determine whether such interactions were
observed in rabbit liver microsomes. In an effort to detect such
changes, we took advantage of the differential effect of CYP1A2 on
CYP2B4-selective PROD and bzp metabolism. Rabbits were treated with
phenobarbital (PB),
-naphthoflavone (
NF), and both PB +
NF
conditions that enrich microsomes with CYP2B4, CYP1A2, or
both enzymes, respectively. Benzphetamine demethylation activity was
equivalently elevated in both the PB and the PB +
NF groups, consistent with the induction of CYP2B4 in both groups. In contrast, PROD activity in the PB +
NF group was less than 25% of that found
in the PB-treated rabbits. These results demonstrate that the
interactions observed in reconstituted systems are not an artifact of
reconstitution but are observed under the more natural conditions of
the microsomal membrane.
This article has been cited by other articles:
![]() |
H. Ouellet, L. M. Podust, and P. R. O. de Montellano Mycobacterium tuberculosis CYP130: CRYSTAL STRUCTURE, BIOPHYSICAL CHARACTERIZATION, AND INTERACTIONS WITH ANTIFUNGAL AZOLE DRUGS J. Biol. Chem., February 22, 2008; 283(8): 5069 - 5080. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. T. Peters, M. R. Meyer, D. S. Theobald, and H. H. Maurer Identification of Cytochrome P450 Enzymes Involved in the Metabolism of the New Designer Drug 4'-Methyl-{alpha}-pyrrolidinobutyrophenone Drug Metab. Dispos., January 1, 2008; 36(1): 163 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ozalp, E. Szczesna-Skorupa, and B. Kemper BIMOLECULAR FLUORESCENCE COMPLEMENTATION ANALYSIS OF CYTOCHROME P450 2C2, 2E1, AND NADPH-CYTOCHROME P450 REDUCTASE MOLECULAR INTERACTIONS IN LIVING CELLS Drug Metab. Dispos., September 1, 2005; 33(9): 1382 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hazai and D. Kupfer INTERACTIONS BETWEEN CYP2C9 AND CYP2C19 IN RECONSTITUTED BINARY SYSTEMS INFLUENCE THEIR CATALYTIC ACTIVITY: POSSIBLE RATIONALE FOR THE INABILITY OF CYP2C19 TO CATALYZE METHOXYCHLOR DEMETHYLATION IN HUMAN LIVER MICROSOMES Drug Metab. Dispos., January 1, 2005; 33(1): 157 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Szczesna-Skorupa, B. Mallah, and B. Kemper Fluorescence Resonance Energy Transfer Analysis of Cytochromes P450 2C2 and 2E1 Molecular Interactions in Living Cells J. Biol. Chem., August 15, 2003; 278(33): 31269 - 31276. [Abstract] [Full Text] [PDF] |
||||